| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.059 | 0.5 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |